Jed A. Latkin
2016
Compensation breakdown
Non-Equity Incentive Plan | $122,903 |
---|---|
Option Awards | $39,992 |
Salary | $163,309 |
Total | $326,204 |
Latkin received $163.3K in salary, accounting for 50% of the total pay in 2016.
Latkin also received $122.9K in non-equity incentive plan and $40K in option awards.
Rankings
In 2016, Jed A. Latkin's compensation ranked 12,459th out of 14,075 executives tracked by ExecPay. In other words, Latkin earned more than 11.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 12,459 | 12th |
Manufacturing | 4,884 | 11th |
Chemicals And Allied Products | 1,732 | 9th |
Drugs | 1,410 | 8th |
In Vitro and In Vivo Diagnostic Substances | 55 | 15th |
Latkin's colleagues
We found six more compensation records of executives who worked with Jed A. Latkin at Navidea Biopharmaceuticals in 2016.
2016
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2016
Thomas Klima
Navidea Biopharmaceuticals
Senior Vice President and Chief Commercial Officer
2016
William Regan
Navidea Biopharmaceuticals
Senior Vice President and Chief Compliance Officer
2016
Brent Larson
Navidea Biopharmaceuticals
Chief Financial Officer
2016
Michael Goldberg
Navidea Biopharmaceuticals
Chief Executive Officer
2016
Ricardo Gonzalez
Navidea Biopharmaceuticals
Chief Executive Officer
News
October 24, 2022
August 2, 2021
July 31, 2020
June 28, 2019